RADIUM-223 CHLORIDE (ALPHARADIN) IMPACT ON OVERALL SURVIVAL AND SKELETAL-RELATED EVENTS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER WITH BONE METASTASES: A PHASE III RANDOMIZED TRIAL (ALSYMPCA)

O. Sartor, D. Heinrich, S.I. Helle, Joe O'Sullivan, A. Chodacki, T. Demkow, J. Logue, M. Seke, A. Widmark, D.C. Johannessen, S. Nilsson, P. Hoskin, A. Solberg, N.D. James, I. Syndikus, N. Vogelzang, C.G. O'Bryan-Tear, J. Garcia-Vargas, M.H. Shan, C. Parker

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)E279-E279
Number of pages1
JournalJournal of Urology
Volume187
Publication statusPublished - May 2012

Cite this